PubMed

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis.

Stockley RA, Whitehead PJ, Williams MK.

Respir Res. 2006 Dec 29;7:147. Review.PMID: 17196106 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-acting beta2-agonists for chronic obstructive pulmonary disease.

Appleton S, Smith B, Veale A, Bara A.

Cochrane Database Syst Rev. 2000;(2):CD001104. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001104. PMID: 10796594 [PubMed - indexed for MEDLINE]Related articles

The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease.

Chapman KR, Arvidsson P, Chuchalin AG, Dhillon DP, Faurschou P, Goldstein RS, Kuipers AF; International study group.

Can Respir J. 2002 May-Jun;9(3):178-85.PMID: 12068339 [PubMed - indexed for MEDLINE]Related articlesFree article

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.PMID: 17310045 [PubMed - indexed for MEDLINE]Related articlesFree article

Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.

Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.

Clin Ther. 2007 Feb;29(2):261-78.PMID: 17472819 [PubMed - indexed for MEDLINE]Related articles

A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.

Broseghini C, Testi R, Polese G, Tosatto R, Rossi A.

Pulm Pharmacol Ther. 2005;18(2):103-8. Epub 2005 Jan 7.PMID: 15649852 [PubMed - indexed for MEDLINE]Related articles

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105. PMID: 12728159 [PubMed - indexed for MEDLINE]Related articlesFree article

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L.

Chest. 2002 Jul;122(1):47-55.PMID: 12114338 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.

Appleton S, Poole P, Smith B, Veale A, Lasserson TJ, Chan MM.

Cochrane Database Syst Rev. 2006 Jul 19;3:CD001104. Review.PMID: 16855959 [PubMed - indexed for MEDLINE]Related articles

Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.

Cote C, Pearle JL, Sharafkhaneh A, Spangenthal S.

Pulm Pharmacol Ther. 2009 Feb;22(1):44-9. Epub 2008 Nov 30.PMID: 19071226 [PubMed - indexed for MEDLINE]Related articles

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Ann Intern Med. 2009 Oct 20;151(8):517-27.PMID: 19841453 [PubMed - indexed for MEDLINE]Related articles

Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation.

Appleton S, Poole P, Smith B, Veale A, Bara A.

Cochrane Database Syst Rev. 2002;(3):CD001104. Review. Update in: Cochrane Database Syst Rev. 2006;3:CD001104. PMID: 12137617 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.

Chest. 2007 Dec;132(6):1756-63. Epub 2007 Oct 20.PMID: 17951625 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation.

Jones PW, Wilson K, Sondhi S.

Respir Med. 2003 Jan;97(1):20-6.PMID: 12556006 [PubMed - indexed for MEDLINE]Related articles

Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.

Briggs DD Jr, Covelli H, Lapidus R, Bhattycharya S, Kesten S, Cassino C.

Pulm Pharmacol Ther. 2005;18(6):397-404. Epub 2005 Apr 25.PMID: 16179215 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular safety of salmeterol in COPD.

Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C.

Chest. 2003 Jun;123(6):1817-24.PMID: 12796155 [PubMed - indexed for MEDLINE]Related articlesFree article

Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Spencer M, Briggs AH, Grossman RF, Rance L.

Pharmacoeconomics. 2005;23(6):619-37.PMID: 15960557 [PubMed - indexed for MEDLINE]Related articles

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.PMID: 17314337 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.PMID: 17916806 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of salmeterol to existing treatment in patients with COPD: a 12 month study.

Stockley RA, Chopra N, Rice L.

Thorax. 2006 Feb;61(2):122-8.PMID: 16443706 [PubMed - indexed for MEDLINE]Related articlesFree article